the presumptive leader is not defined, which leads to uncertainty and delays when leadership and action is needed,'' the report says...
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.. august 2011 (23). if you would like to add a comment, please register or log in .